At any given time, thousands of people in the United States are taking part in clinical trials – proving grounds for novel medical therapies and devices.
What events and circumstances open one's eyes to the marvel of science and experimentation?
Biomedical researchers are struggling these days to fuel scientific pursuits. Cuts to the National Institutes of Health (NIH) budget are squeezing many investigators, particularly those early in their careers.
The National Academy of Sciences this week announced its annual election of new members and foreign associates in recognition of their distinguished and continuing achievements in original research.
Much has been assumed about the private and public damage of scientific misconduct. Yet few have tried to measure the costs to perpetrators and to society.
Dr. Francis Collins, director of the National Institutes of Health (NIH), and U.S. Sen.
For the first time, two Seattle powerhouses in brain research are collaborating to teach the next generation of neuroscientists.
[See original HSNewsBeat story, "Clot drug tested with suspected brain injuries" from July 1, 2014.
[See related Q&A with Dr. Eileen Bulger from July 28.]
[Editors’ note: This is the fifth in a series of seven articles about bioethics.